Close
Smartlab Europe
Inizio Ignite

News

Boosting the taste, stability and shelf-life of probiotic supplements

During the virtual CPhI Festival of Pharma (5–16 October), BENEO will showcase galenIQ 721 for probiotic supplements. galenIQ 721 is the agglomerated form of BENEO’s pharmaceutical-grade Isomalt. Supporting the viability of micro-organisms, the sweet-tasting excipient is suitable for probiotic powders,...

Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events

Informa Markets announces its complete listing of pharma event dates for 2021 at the opening of the first CPhI Festival of Pharma (05 - 16 October 2020) – the largest ever virtual pharma event. The pharma schedule includes one further...

Bharat Biotech’s Covid-19 vaccine to use ViroVax’s adjuvant for longer-lasting immunity

Vaccines major Bharat Biotech on Monday announced its coronavirus disease (Covid-19) vaccine Covaxin will use adjuvant Alhydroxiquim-II to boost immune response. An adjuvant is a pharmacological or immunological agent that improves the immune response of a vaccine by producing more...

Omnicell Completes Acquisition of Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business

Omnicell, Inc., a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that it has completed the previously announced acquisition of Pharmaceutical Strategies Group’s (PSG) 340B Link business, pursuant to the terms...

Siegfried to Acquire Two Pharmaceutical Manufacturing Sites from Novartis in Spain

Siegfried has signed binding agreements with Novartis regarding the acquisition of two pharmaceutical manufacturing sites in Spain. With this acquisition, Siegfried will significantly enhance its global production network in terms of capacity and technological capabilities and will achieve the...

BMS Announces Update on CheckMate -915 Evaluating Opdivo Plus Yervoy Versus Opdivo in Resected High-Risk Melanoma Patients

Bristol Myers Squibb announced results for the co-primary endpoint for CheckMate -915, a randomized Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) versus Opdivo for patients who have had a complete surgical removal of stage IIIb/c/d or stage...

EMA starts first rolling review of a COVID-19 vaccine in the EU

EMA’s human medicines committee (CHMP) has started the first ‘rolling review’ of a COVID-19 vaccine, which is being developed by the company AstraZeneca in collaboration with the University of Oxford. The start of the rolling review means that the committee...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »